Abbott India stops importing Xience Alpine stentsAbbott becomes the first company to officially stop imports of the drug-eluting cardiac stents on account of the price curbs.
Government blocks companies from withdrawing stents until December 2017The Department of Pharmaceuticals has directed stent importers and domestic manufacturers to maintain their production, import and supply f...
Government forbids cos from withdrawing stents until December to prevent shortageThe move may affect multinational cos that have been trying to withdraw their high-end stents from India after the drug pricing watchdog ca...
NPPA tells Boston Scientific to resubmit applications on premier stent brandsFive months after it was blocked from discontinuing its brands 'Promus Premier' & 'Synergy' in India, Boston Scientific has approached NPPA...
Supply all knee implant brands, government tells companiesThe move is expected to preempt any shortages and ensure uninterrupted supply of a variety of high quality primary and revision knee implan...
Pricing regulator says Abbott can discontinue premium 'Xience Alpine' stent in a yearAbbott had moved to withdraw Alpine citing that selling the product here was unviable after the maximum prices of all drug-eluting stents w...
Abbott allowed to discontinue dissolvable stent in IndiaThe company asserted that its decision to withdraw Abbott was based on “low commercial uptake” and this was reflected in the sales figures ...
Government to revisit stent price control in FebruaryThe government is expected to hold discussions to decide on these requests only in February, a year after it first capped prices of these l...
After dissolvable stent 'Absorb', Abbott moves to withdraw 'Xience Alpine'Abbott publicly announced intentions to stop global sales of dissolvable scaffold ‘Absorb’, which has been mired in controversy for risks r...
Abbott to stop sales of bioresorbable stent 'Absorb', moves to withdraw it in IndiaAbbott’s move also comes while several regulators in different countries have scrutinised this scaffold, used in life saving procedures, ov...
NPPA rejects Abbott, Medtronic's request to withdraw latest stentsThe companies sought to withdraw Abbott’s Xience Alpine and Absorb, and Medtronic’s Resolute Onyx stents after NPPA slashed their prices by...
Stent Abbott wants to pull out is `identical' to othersAbbott is selling its drug eluting stents, including the Xience Alpine, for the equivalent of Rs 29,000 to Rs 33,000 in many European count...
Centre cracks whip, no stent can be withdrawn, for nowThe department of pharmaceuticals (DoP) said it had come across reports regarding shortage of coronary stents in the market and in hospital...
The cuts that complicate efforts to cap stent priceSince hospitals implant the stent, they also become de facto retailers as the devices cannot be bought in the open market.
SMT to conduct quality trials of its stents in EuropeThe company will test the quality, safety and efficacy of 86 variations of Supraflex stents against their Xience equivalents between now an...
Now a stent made from polylactic acid,will lead to fewer complications in heart patientsDoctors are using device to treat those too ill for open-heart surgery to try and restore normal blood circulation by preventing mitral val...
GB Pant rip-off: Doctors fancy costly stentsNow patients are being told that the stent costing Rs 42,000 is better in quality than the one that costs Rs 23,625.